145 related articles for article (PubMed ID: 26456246)
1. Carboxymethyl starch mucoadhesive microspheres as gastroretentive dosage form.
Lemieux M; Gosselin P; Mateescu MA
Int J Pharm; 2015 Dec; 496(2):497-508. PubMed ID: 26456246
[TBL] [Abstract][Full Text] [Related]
2. The influence of protonation ratio on properties of carboxymethyl starch excipient at various substitution degrees: Structural insights and drug release kinetics.
Assaad E; Mateescu MA
Int J Pharm; 2010 Jul; 394(1-2):75-84. PubMed ID: 20435114
[TBL] [Abstract][Full Text] [Related]
3. The NCI-N87 cell line as a gastric epithelial barrier model for drug permeability assay.
Lemieux M; Bouchard F; Gosselin P; Paquin J; Mateescu MA
Biochem Biophys Res Commun; 2011 Sep; 412(3):429-34. PubMed ID: 21821011
[TBL] [Abstract][Full Text] [Related]
4. Influence of drying procedure and of low degree of substitution on the structural and drug release properties of carboxymethyl starch.
Lemieux M; Gosselin P; Mateescu MA
AAPS PharmSciTech; 2010 Jun; 11(2):775-85. PubMed ID: 20443088
[TBL] [Abstract][Full Text] [Related]
5. Carboxymethyl starch and lecithin complex as matrix for targeted drug delivery: I. Monolithic mesalamine forms for colon delivery.
Mihaela Friciu M; Canh Le T; Ispas-Szabo P; Mateescu MA
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):521-30. PubMed ID: 23562535
[TBL] [Abstract][Full Text] [Related]
6. Characterization of different substituted carboxymethyl starch microgels and their interactions with lysozyme.
Zhang B; Tao H; Wei B; Jin Z; Xu X; Tian Y
PLoS One; 2014; 9(12):e114634. PubMed ID: 25490774
[TBL] [Abstract][Full Text] [Related]
7. Carboxymethyl high amylose starch as excipient for controlled drug release: mechanistic study and the influence of degree of substitution.
Lemieux M; Gosselin P; Mateescu MA
Int J Pharm; 2009 Dec; 382(1-2):172-82. PubMed ID: 19716866
[TBL] [Abstract][Full Text] [Related]
8. Developments on carboxymethyl starch-based smart systems as promising drug carriers: A review.
Pooresmaeil M; Namazi H
Carbohydr Polym; 2021 Apr; 258():117654. PubMed ID: 33593542
[TBL] [Abstract][Full Text] [Related]
9. Carboxymethyl Starch Excipients for Drug Chronodelivery.
Ispas-Szabo P; De Koninck P; Calinescu C; Mateescu MA
AAPS PharmSciTech; 2017 Jul; 18(5):1673-1682. PubMed ID: 27686941
[TBL] [Abstract][Full Text] [Related]
10. [Study on the mitoxantrone carboxymethyl starch microspheres for hepatic artery chemoembolization].
Zhang Z; Wei Z; Wang L; Liao F
Yao Xue Xue Bao; 1998 Oct; 33(10):772-7. PubMed ID: 12016932
[TBL] [Abstract][Full Text] [Related]
11. Carboxymethyl starch/montmorillonite composite microparticles: Properties and controlled release of isoproturon.
Wilpiszewska K; Spychaj T; Paździoch W
Carbohydr Polym; 2016 Jan; 136():101-6. PubMed ID: 26572334
[TBL] [Abstract][Full Text] [Related]
12. Polyelectrolyte complex of carboxymethyl starch and chitosan as protein carrier: oral administration of ovalbumin.
Assaad E; Blemur L; Lessard M; Mateescu MA
J Biomater Sci Polym Ed; 2012; 23(13):1713-28. PubMed ID: 21967707
[TBL] [Abstract][Full Text] [Related]
13. Drug release from starch-acetate microparticles and films with and without incorporated alpha-amylase.
Tuovinen L; Peltonen S; Liikola M; Hotakainen M; Lahtela-Kakkonen M; Poso A; Järvinen K
Biomaterials; 2004 Aug; 25(18):4355-62. PubMed ID: 15046926
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites.
Akiyama Y; Nagahara N; Nara E; Kitano M; Iwasa S; Yamamoto I; Azuma J; Ogawa Y
J Pharm Pharmacol; 1998 Feb; 50(2):159-66. PubMed ID: 9530983
[TBL] [Abstract][Full Text] [Related]
15. Enhanced in vitro permeation of furosemide loaded into thermally carbonized mesoporous silicon (TCPSi) microparticles.
Kaukonen AM; Laitinen L; Salonen J; Tuura J; Heikkilä T; Limnell T; Hirvonen J; Lehto VP
Eur J Pharm Biopharm; 2007 Jun; 66(3):348-56. PubMed ID: 17240128
[TBL] [Abstract][Full Text] [Related]
16. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization.
Albertini B; Passerini N; Di Sabatino M; Monti D; Burgalassi S; Chetoni P; Rodriguez L
Int J Pharm; 2010 Oct; 399(1-2):71-9. PubMed ID: 20696227
[TBL] [Abstract][Full Text] [Related]
17. Starch-based nanocapsules fabricated through layer-by-layer assembly for oral delivery of protein to lower gastrointestinal tract.
Zhang Y; Chi C; Huang X; Zou Q; Li X; Chen L
Carbohydr Polym; 2017 Sep; 171():242-251. PubMed ID: 28578960
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical and release properties of carboxymethylated starches of Dioscorea from Jharkhand.
Vashisht D; Pandey A; Jayaram Kumar K
Int J Biol Macromol; 2015 Mar; 74():523-9. PubMed ID: 25561049
[TBL] [Abstract][Full Text] [Related]
19. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability.
Tao Y; Lu Y; Sun Y; Gu B; Lu W; Pan J
Int J Pharm; 2009 Aug; 378(1-2):30-6. PubMed ID: 19465102
[TBL] [Abstract][Full Text] [Related]
20. Nanoprecipitation with sonication for enhancement of oral bioavailability of furosemide.
Sahu BP; Das MK
Acta Pol Pharm; 2014; 71(1):129-37. PubMed ID: 24779201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
